Tecentriq (atezolizumab)
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Tecentriq (atezolizumab), covering 2024-10-17 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer [Phase 2]